(Q39236041)

10 September 2017

title

Relation of nocturnal polyuria of the elderly to essential hypertension (English)

1 reference

10 September 2017

main subject

arterial hypertension

0 references

1 reference

P M McKeigue

1

1 reference

10 September 2017

J M Reynard

series ordinal

2

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

10 September 2017

1 reference

10 September 2017

volume

355

1 reference

10 September 2017

issue

9202

1 reference

10 September 2017

page(s)

486-488

1 reference

Urinary symptoms in the community: how bothersome are they?

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Troublesome lower urinary tract symptoms in the community: a prevalence study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Nocturia: a risk factor for falls in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

The effect of prostatectomy on symptom severity and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Mortality in the elderly in relation to nocturnal micturition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Frequency-volume charts: comparison of frequency between elderly and adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Role of atrial natriuretic peptide in nocturnal polyuria in elderly males

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Symptom status and quality of life following prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Basis of nocturnal polyuria in patients with autonomic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Desmopressin in the treatment of nocturnal polyuria in the male

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Change in symptoms of hypertensive patients after referral to hospital clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

The assessment of the relationship between blood pressure and sodium intake using whole-day, daytime and overnight urine collections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Prophylactic treatment of adult nocturia with bumetanide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Diurnal change in plasma atrial natriuretic peptide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Haemodynamic and renal effects of urodilatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Basal nitric oxide synthesis in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Nifedipine and nocturia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2982039-5

7 January 2021

10.1016/S0140-6736(00)82039-5

Identifiers

DOI

1 reference

10 September 2017

1 reference